Back

Lipid assessment and target attainment in acute coronary syndrome: a 10-year comparative review in a UK tertiary centre.

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering agents: review, meta-analysis, efficacy, and clinical outcomes Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Aparna Thomas

Nottingham University Hospitals NHS Trust, Nottingham (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonist decreases VLDL-induced lipid accumulation in cardiomyocyte
Mr J. Chang (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Real-world use of bempedoic acid for ASCVD risk reduction in a rural UK primary care practice: Analysing trends in LDL-C reduction, adherence, and ESC target attainment
Mrs M. Donaldson (Louth, GB)
Abstract Slides Video
Presentation thumbnail
Heterogeneous biomarker responses to CETP inhibitors: a phase 3 trials systematic review and network meta-analysis
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Class effects of subcutaneous lipoprotein(a)-lowering therapies: a systematic review and meta-analysis
Doctor M. Dogan (Greenville, US)
Abstract Slides Video
Presentation thumbnail
Comparative LDL-C Reduction and Cardiovascular Outcomes With PCSK9-Pathway Therapies: A Systemic Review and Network Meta-Analysis
Doctor H. Ramteke (Chimur, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering agents: review, meta-analysis, efficacy, and clinical outcomes

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
How good/bad are we in achieving target LDLs post ACS?
18 March 2022
thumbnail
Congress Presentation
Closing the secondary prevention gap in acute coronary syndrome through system-level metabolic risk standardisation
29 August 2026
thumbnail
Congress Presentation
Cumulative LDL-cholesterol exposure after Index percutaneous coronary intervention and subsequent major adverse cardiac and cerebrovascular events
28 August 2026
thumbnail
Congress Presentation
Cardiovascular risk and LDL-C target attainment in cardiology inpatients: insights from the CARDIO study
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources